BLCO Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—Forward 13.33
EPS (TTM)$-0.62-88.6% YoY
Profit margin-4.2%HEALTHCARE
Market cap$5.31BMid cap
Wall Street coverage
$17.88median target· current $15.09 (+18.5%)13 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 13.33
- PEG ratio
- 0.89
- P/B
- 0.83
- P/S (TTM)
- 1.02
- EV/EBITDA
- 15.91
Profitability & growth
- ROE (TTM)
- -3.3%
- Operating margin
- 4.7%
- Revenue growth YoY
- 9.4%
- Dividend yield
- —
- Beta
- 0.57
Last earnings
Apr 29, 2026 · Estimate $0.05 · Reported $0.08
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Bausch + Lomb Corp
Company profileBausch Lomb Corporation is an eye health company in Canada and internationally. The company is headquartered in Vaughan, Canada.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 520 APPLEWOOD CRESCENT, VAUGHAN, ON
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$5.31B
Shares outstanding$356.5M
52W high$18.91
52W low$11.58
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent